http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012523434-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-23 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012523434-A |
| titleOfInvention | Amylin agonist compounds for estrogen-deficient mammals |
| abstract | The present invention provides a method of treating estrogen deficiency in a mammal in need of treatment by administering to the estrogen deficient mammal a therapeutically effective amount of an amylin agonist compound or a pharmaceutical composition comprising an amylin agonist compound. The methods of the invention can further comprise improving glycemic control in an estrogen-deficient mammal by administering to the estrogen-deficient mammal a therapeutically effective amount of an amylin agonist compound or a pharmaceutical composition comprising an amylin agonist compound. Improvement of blood glucose management includes reduction of blood glucose level, reduction of hemoglobin A1c (HbA1c) level, and the like. In one embodiment, the estrogen-deficient mammal has diabetes, such as type 2 diabetes, and is overweight or obese. |
| priorityDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 459.